Cargando…
Curcumin Inhibits the Primary Nucleation of Amyloid-Beta Peptide: A Molecular Dynamics Study
The amyloid plaques are a key hallmark of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease. Amyloidogenesis is a complex long-lasting multiphase process starting with the formation of nuclei of amyloid peptides: a process assigned as a primary nucleation. Curcumin (CU)...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563689/ https://www.ncbi.nlm.nih.gov/pubmed/32942739 http://dx.doi.org/10.3390/biom10091323 |
_version_ | 1783595543794024448 |
---|---|
author | Doytchinova, Irini Atanasova, Mariyana Salamanova, Evdokiya Ivanov, Stefan Dimitrov, Ivan |
author_facet | Doytchinova, Irini Atanasova, Mariyana Salamanova, Evdokiya Ivanov, Stefan Dimitrov, Ivan |
author_sort | Doytchinova, Irini |
collection | PubMed |
description | The amyloid plaques are a key hallmark of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease. Amyloidogenesis is a complex long-lasting multiphase process starting with the formation of nuclei of amyloid peptides: a process assigned as a primary nucleation. Curcumin (CU) is a well-known inhibitor of the aggregation of amyloid-beta (Aβ) peptides. Even more, CU is able to disintegrate preformed Aβ firbils and amyloid plaques. Here, we simulate by molecular dynamics the primary nucleation process of 12 Aβ peptides and investigate the effects of CU on the process. We found that CU molecules intercalate among the Aβ chains and bind tightly to them by hydrogen bonds, hydrophobic, π–π, and cation–π interactions. In the presence of CU, the Aβ peptides form a primary nucleus of a bigger size. The peptide chains in the nucleus become less flexible and more disordered, and the number of non-native contacts and hydrogen bonds between them decreases. For comparison, the effects of the weaker Aβ inhibitor ferulic acid (FA) on the primary nucleation are also examined. Our study is in good agreement with the observation that taken regularly, CU is able to prevent or at least delay the onset of neurodegenerative disorders. |
format | Online Article Text |
id | pubmed-7563689 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75636892020-10-27 Curcumin Inhibits the Primary Nucleation of Amyloid-Beta Peptide: A Molecular Dynamics Study Doytchinova, Irini Atanasova, Mariyana Salamanova, Evdokiya Ivanov, Stefan Dimitrov, Ivan Biomolecules Article The amyloid plaques are a key hallmark of neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease. Amyloidogenesis is a complex long-lasting multiphase process starting with the formation of nuclei of amyloid peptides: a process assigned as a primary nucleation. Curcumin (CU) is a well-known inhibitor of the aggregation of amyloid-beta (Aβ) peptides. Even more, CU is able to disintegrate preformed Aβ firbils and amyloid plaques. Here, we simulate by molecular dynamics the primary nucleation process of 12 Aβ peptides and investigate the effects of CU on the process. We found that CU molecules intercalate among the Aβ chains and bind tightly to them by hydrogen bonds, hydrophobic, π–π, and cation–π interactions. In the presence of CU, the Aβ peptides form a primary nucleus of a bigger size. The peptide chains in the nucleus become less flexible and more disordered, and the number of non-native contacts and hydrogen bonds between them decreases. For comparison, the effects of the weaker Aβ inhibitor ferulic acid (FA) on the primary nucleation are also examined. Our study is in good agreement with the observation that taken regularly, CU is able to prevent or at least delay the onset of neurodegenerative disorders. MDPI 2020-09-15 /pmc/articles/PMC7563689/ /pubmed/32942739 http://dx.doi.org/10.3390/biom10091323 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Doytchinova, Irini Atanasova, Mariyana Salamanova, Evdokiya Ivanov, Stefan Dimitrov, Ivan Curcumin Inhibits the Primary Nucleation of Amyloid-Beta Peptide: A Molecular Dynamics Study |
title | Curcumin Inhibits the Primary Nucleation of Amyloid-Beta Peptide: A Molecular Dynamics Study |
title_full | Curcumin Inhibits the Primary Nucleation of Amyloid-Beta Peptide: A Molecular Dynamics Study |
title_fullStr | Curcumin Inhibits the Primary Nucleation of Amyloid-Beta Peptide: A Molecular Dynamics Study |
title_full_unstemmed | Curcumin Inhibits the Primary Nucleation of Amyloid-Beta Peptide: A Molecular Dynamics Study |
title_short | Curcumin Inhibits the Primary Nucleation of Amyloid-Beta Peptide: A Molecular Dynamics Study |
title_sort | curcumin inhibits the primary nucleation of amyloid-beta peptide: a molecular dynamics study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563689/ https://www.ncbi.nlm.nih.gov/pubmed/32942739 http://dx.doi.org/10.3390/biom10091323 |
work_keys_str_mv | AT doytchinovairini curcumininhibitstheprimarynucleationofamyloidbetapeptideamoleculardynamicsstudy AT atanasovamariyana curcumininhibitstheprimarynucleationofamyloidbetapeptideamoleculardynamicsstudy AT salamanovaevdokiya curcumininhibitstheprimarynucleationofamyloidbetapeptideamoleculardynamicsstudy AT ivanovstefan curcumininhibitstheprimarynucleationofamyloidbetapeptideamoleculardynamicsstudy AT dimitrovivan curcumininhibitstheprimarynucleationofamyloidbetapeptideamoleculardynamicsstudy |